2026 ICD-10-CM Diagnosis Code M30.0Polyarteritis nodosa

ICD-10-CM Codes›M00–M99›M30-M36›M30

ICD-10-CM M30.0
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

M30.0 is a billable ICD-10-CM diagnosis code for polyarteritis nodosa. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 545 through 547. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 74 closely related codes. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Systemic lupus erythematosus and connective tissue disorders and Vasculitis.

For Medicare Advantage risk adjustment, M30.0 maps to CMS-HCC Category 94 (Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders) under the V28 model, adding a risk factor of about 0.268 for a community, non-dual, aged beneficiary in payment year 2026.

Code Identity

ICD-10-CM Code
M30.0
Billable Status
Yes — Valid for Submission
Code Describes
Polyarteritis nodosa
Short Description
Polyarteritis nodosa
Same as the full description in the CMS dataset.
Parent Code
Polyarteritis nodosa and related conditions

Code Classification

ChapterM00–M99Diseases of the musculoskeletal system and connective tissue
SectionM30-M36Systemic connective tissue disorders
CategoryM30Polyarteritis nodosa and related conditions
This CodeM30.0Polyarteritis nodosa

Medicare Risk Adjustment (HCC)Billing

M30.0 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.

CMS-HCC V28 Category (Payment Model)
HCC 94— Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders
Payment HCC · PY 2026 one of 71 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.268
community, non-dual, aged · ranges 0.196–0.297 across segments
Hierarchy
Superseded by HCC 93
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 40
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 40 · ESRD (V21): HCC 40 · ESRD (V24): HCC 40
ESRD V21 weights: 0.072 dialysis, 0.274–0.398 functioning graft · ESRD V24 weights: 0.058 dialysis, 0.284–0.414 functioning graft
Part D (RxHCC)
RxHCC 84 — Systemic Lupus Erythematosus and Other Systemic Connective Tissue Disorders
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Benign cutaneous periarteritis nodosa
  • Cutaneous polyarteritis nodosa
  • Dementia due to polyarteritis nodosa
  • Myopathy due to polyarteritis nodosa
  • Nephrotic syndrome in polyarteritis nodosa
  • Periarteritis
  • Polyarteritis
  • Polyarteritis nodosa
  • Polyarteritis nodosa with multi-organ involvement
  • Polyarteritis nodosa with single organ involvement
  • Polyneuropathy in collagen vascular disease
  • Polyneuropathy in polyarteritis nodosa
  • Primary systemic arteritis
  • Retinal vasculitis due to polyarteritis nodosa
  • Vasculitis due to systemic disease
  • Vasculitis of medium sized vessel

Index to Diseases and InjuriesGuidance

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MUS024
Systemic lupus erythematosus and connective tissue disorders
Default principal diagnosis: inpatient Yes · outpatient Yes
CCSR CIR037
Vasculitis
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Polyarteritis Nodosa

    a form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized arteries, often with microaneurysms. it is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. polyarteritis nodosa with lung involvement is called churg-strauss syndrome.

Patient EducationClinical

Vasculitis

Vasculitis is an inflammation of the blood vessels. It happens when the body's immune system attacks the blood vessel by mistake. It can happen because of an infection, a medicine, or another disease. The cause is often unknown.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert M30.0 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
446.0 Polyarteritis nodosa
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About M30.0Overview

What is the ICD-10 code for polyarteritis nodosa?

The ICD-10-CM code for polyarteritis nodosa is M30.0 (sometimes written as M300). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is M30.0 (Polyarteritis nodosa and related conditions) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report polyarteritis nodosa on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does M30.0 group to?

When polyarteritis nodosa is the principal diagnosis on an inpatient stay, it groups to MS-DRG 545, 546, 547, with relative weights from 0.8362 to 2.4817 depending on complications. Higher weights mean higher Medicare reimbursement.

Is M30.0 a CC or MCC?

CMS lists M30.0 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 74 closely related codes in its exclusion list.

What is the ICD-9 equivalent of M30.0?

Under the General Equivalence Mappings, polyarteritis nodosa converts to ICD-9-CM 446.0 (polyarteritis nodosa). The mapping is approximate, so confirm the match fits the documentation.

What HCC is M30.0?

M30.0 (polyarteritis nodosa) maps to CMS-HCC Category 94 (Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders), commonly written as HCC 94, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 40 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 84.

Does M30.0 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, M30.0 adds a risk adjustment factor of about 0.268 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.196 to 0.297 depending on the payment segment). A more severe related category (HCC 93) supersedes it when both are reported. See the full factor table on the HCC 94 category page.